Glasgow Scientists Find New Way to Stop Deadly Cancers

Scientists at the Cancer Research UK Scotland Institute just found a promising new weapon against two of Scotland's deadliest cancers.

The Glasgow team discovered that blocking a specific protein could stop liver and bowel cancers from growing. These two diseases claim over 2,300 Scottish lives every year.

The breakthrough centers on how cancer cells hijack something called the WNT pathway. This is the body's natural system for telling cells when to grow and when to stop growing.

When genetic faults occur in this pathway, cancer cells exploit it to grow tumors in the intestine and liver. The researchers found that a protein called nucleophosmin, or NPM1, appears in unusually high levels in these cancers.

Here's where it gets exciting. By blocking NPM1, the research team may have found a way to stop these specific cancers without damaging healthy tissue.

Lead researcher Professor Owen Sansom explained why this matters so much. "Because NPM1 isn't essential for normal adult tissue health, blocking it could be a safe way to treat certain cancers, like some hard-to-treat bowel and liver cancers," he said.

The science is elegant. When NPM1 gets removed, cancer cells can't make proteins properly. This allows a natural tumor suppressor to activate and prevent cancer growth.

Bowel cancer alone kills around 1,700 people in Scotland each year, making it the second most common cause of cancer death in the country. Liver cancer claims another 670 lives annually.

The Ripple Effect

This discovery could transform treatment options for patients facing limited choices today. As cancer rates continue rising, especially among younger people, new approaches become increasingly vital.

The timing matters because current treatments don't work for all patients with these cancers. Some bowel and liver cancers remain particularly stubborn and hard to treat with existing therapies.

Professor Sansom emphasized the urgency. "Increasing numbers of people are affected by these cancers, with some treatments limited for some patients, so finding a new way to tackle these cancers is crucial," he said.

The research team published their findings in Nature Genetics, one of the world's leading scientific journals. This peer review process confirms the discovery meets rigorous scientific standards.

The next steps involve developing actual drugs that can block NPM1 in human patients. While that process takes time, this research provides the crucial foundation that makes new treatments possible.

For the thousands of families touched by liver and bowel cancer each year, this Glasgow breakthrough offers something precious: hope backed by solid science.